Presentation and Management of Silicone Lymphadenopathy: A Single Institutional Retrospective Cohort Study.

Aesthetic plastic surgery 2025 Vol.49(12) p. 3417-3424

Desai A, Smartz T, Tabibi O, Borowsky PA, Tadisina KK, Singh DP, Kesmodel SB, Rojas KE, Mella-Catinchi JR

관련 도메인

Abstract

[INTRODUCTION] Silicone Lymphadenopathy (SL) is a complication of breast implants that involves migration of silicone to nearby soft tissue/lymph nodes. Data on its clinical features and management is scarce. We aimed to identify the clinical presentation and management of SL.

[METHODS] A single-institution retrospective cohort study was conducted from our institutional imaging system where search terms "Silicone lymphadenopathy", "silicone adenitis" and "silicone adenopathy" were used to identify patients with SL (January 2016-September 2023). Patient demographics, clinical features, imaging findings, pathological investigation, and treatment were obtained from the medical records.

[RESULTS] Of 52 patients with SL, breast augmentation accounted for 90.4% of the implant placements. All patients had silicone implants placed at some time. A significant portion of patients (69.3%) were asymptomatic, while 7.7% had non-tender lymphadenopathy, 19.2% experienced painful lymphadenopathy, and 1.9% presented with mixed symptoms. Implant rupture was observed in 88.7% of cases; 13.0% intracapsular, 26.1% extracapsular, 15.2% both, and unknown in 45.7%. Axillary nodes were the most commonly involved (86.5%), and ultrasonography was most commonly used to detect SL (80.7%). Biopsy was performed in 17.3% of cases, confirming benign pathology in all cases. No patients required surgical excision of lymph nodes for management of SL.

[CONCLUSION] Most patients with SL are asymptomatic and are managed with observation. Biopsy and surgical intervention should be reserved for those patients with abnormal imaging or persistent symptoms. Evaluation of lymphadenopathy is essential to exclude malignancy in patients with a history of breast cancer.

[LEVEL OF EVIDENCE III] This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 breast 유방 dict 3
시술 breast augmentation 유방성형술 dict 1
합병증 implant rupture 보형물 파열 dict 1
약물 silicone C0037114
silicones
scispacy 1
약물 [INTRODUCTION] Silicone Lymphadenopathy scispacy 1
질환 Silicone Lymphadenopathy scispacy 1
질환 tissue/lymph scispacy 1
질환 silicone adenitis scispacy 1
질환 silicone adenopathy scispacy 1
질환 lymphadenopathy C0497156
Lymphadenopathy
scispacy 1
질환 malignancy C0006826
Malignant Neoplasms
scispacy 1
질환 breast cancer C0006142
Malignant neoplasm of breast
scispacy 1
질환 soft tissue/lymph nodes scispacy 1
질환 non-tender lymphadenopathy scispacy 1
질환 Biopsy scispacy 1
기타 patients scispacy 1
기타 Patient scispacy 1
기타 Axillary nodes scispacy 1
기타 lymph nodes scispacy 1

MeSH Terms

Humans; Retrospective Studies; Female; Breast Implants; Lymphadenopathy; Adult; Middle Aged; Silicone Gels; Breast Implantation; Cohort Studies; Lymph Nodes

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문